Evidence map›Paper›PMID 38999973›Full record

ArticleInternational journal of molecular sciences2024

Idiosyncratic Drug-Induced Liver Injury and Amoxicillin-Clavulanate: Spotlight on Gut Microbiota, Fecal Metabolome and Bile Acid Profile in Patients.

Sara Román-Sagüillo, Raisa Quiñones Castro, María Juárez-Fernández, Polina Soluyanova, Camilla Stephens, Mercedes Robles-Díaz, Francisco Jorquera Plaza, Javier González-Gallego, Susana Martínez-Flórez, María Victoria García-Mediavilla and 3 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. [Gut microbiota-associated metabolites with drug-induced liver injury].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026
    Review
  5. Article
  6. Review
  7. Susceptibility Factor TNF-α Synergizes withJournal of inflammation research · 2025
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sara Román-SagüilloInstituto Universitario de Biomedicina (IBIOMED), Universidad de León, 24071 León, Spain.ORCID 0000-0002-4200-7919
Raisa Quiñones CastroServicio de Aparato Digestivo, Complejo Asistencial Universitario de León, 24008 León, Spain.ORCID 0000-0003-2446-9068
María Juárez-FernándezInstituto Universitario de Biomedicina (IBIOMED), Universidad de León, 24071 León, Spain.ORCID 0000-0003-4678-3058
Polina SoluyanovaUnidad Mixta de Investigación en Hepatología Experimental, IIS Hospital La Fe, 46026 Valencia, Spain.ORCID 0000-0001-5580-7491
Camilla StephensCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Mercedes Robles-DíazCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-2365-2787
Francisco Jorquera PlazaInstituto Universitario de Biomedicina (IBIOMED), Universidad de León, 24071 León, Spain.ORCID 0000-0002-1799-2881
Javier González-GallegoInstituto Universitario de Biomedicina (IBIOMED), Universidad de León, 24071 León, Spain.ORCID 0000-0002-4386-9342
Susana Martínez-FlórezInstituto Universitario de Biomedicina (IBIOMED), Universidad de León, 24071 León, Spain.
María Victoria García-MediavillaInstituto Universitario de Biomedicina (IBIOMED), Universidad de León, 24071 León, Spain.
Esther NistalInstituto Universitario de Biomedicina (IBIOMED), Universidad de León, 24071 León, Spain.ORCID 0000-0002-2201-5575
Ramiro JoverCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-4914-5804
Sonia Sánchez-CamposInstituto Universitario de Biomedicina (IBIOMED), Universidad de León, 24071 León, Spain.ORCID 0000-0003-2672-734X

Funding

Instituto de Salud Carlos III (ISCIII) PI20/00690Junta de Castilla y León and the European Regional Development Fund GRS2126/A/2020Junta de Castilla y León and the European Regional Development Fund LE017-P20Ministerio de Ciencia, Innovación y Universidades PID2020-120363RB-I00
6 · The paper itself

Abstract

Several hepatic disorders are influenced by gut microbiota, but its role in idiosyncratic drug-induced liver injury (iDILI), whose main causative agent is amoxicillin-clavulanate, remains unknown. This pioneering study aims to unravel particular patterns of gut microbiota composition and associated metabolites in iDILI and iDILI patients by amoxicillin-clavulanate (iDILI-AC). Thus, serum and fecal samples from 46 patients were divided into three study groups: healthy controls (n = 10), non-iDILI acute hepatitis (n = 12) and iDILI patients (n = 24). To evaluate the amoxicillin-clavulanate effect, iDILI patients were separated into two subgroups: iDILI non-caused by amoxicillin-clavulanate (iDILI-nonAC) (n = 18) and iDILI-AC patients (n = 6). Gut microbiota composition and fecal metabolome plus serum and fecal bile acid (BA) analyses were performed, along with correlation analyses. iDILI patients presented a particular microbiome profile associated with reduced fecal secondary BAs and fecal metabolites linked to lower inflammation, such as dodecanedioic acid and pyridoxamine. Moreover, certain taxa like

Indexed as

Amoxicillin-Potassium Clavulanate CombinationBile Acids and SaltsChemical and Drug Induced Liver InjuryFecesGastrointestinal MicrobiomeMetabolomeAdultAgedFemaleHumansMaleMiddle AgedAmoxicillin-Potassium Clavulanate CombinationBile Acids and Saltsamoxicillin–clavulanatebile acidsdrug-induced liver diseasefecal metabolomegut microbiota

Identifiers

PMID38999973
PMCPMC11241776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.